News Report | January 14, 2021
Fresenius Selects Tridiuum Platform For Integrated Behavioral Health Program For People Living With Kidney Disease
Fresenius Medical Care North America (FMCNA), which operates dialysis centers, is using Tridiuum’s digital behavioral health solutions for a pilot to proactively identify consumers being treated for chronic kidney disease (CKD) who also have behavioral health issues, such as depression or anxiety. The six-month pilot will begin with four dialysis centers in North Georgia. The participating centers will integrate the Tridiuum ONE platform into clinical workflows.
At the pilot centers, consumers will be prompted to complete behavioral health status assessments at the point of care. The Tridiuum ONE platform will analyze those assessments to calculate a behavioral risk . . .